E.I. Sokolov, R. Shtin, N.V. Bayurova, V.V. Vikentyev, A.G. Goncharova, L.H. Bragin

In modern domestic and foreign literature many works indicating participation of immunity mechanisms in pathogenesis of many diseases of cardiovascular system, including the coronary heart disease (IBS) which morphological substratum in most cases is atherosclerotic defeat of coronary vessels are executed. We carried out a comprehensive evaluation of cellular and humoral immunity, nonspecific inflammation markers and their relationship to the thickness of the intima-media of the carotid arteries and the impact of changes in these parameters on the nature of coronary artery disease. The study included 44 patients with chronic forms of coronary artery disease and 35 healthy individuals. Shows the activation of predominantly innate immunity, subpopulations of T-lymphocytes responsible for the production of proinflammatory cytokines in patients with coronary artery disease. A positive correlation between the level of C-reactive protein, circulating immune complexes, the thickness of the intima-media of the carotid arteries, and CD4 + CD25 +-T-lymphocytes, CD56, 16 + - NK-cells in patients with coronary artery disease and the severity of coronary artery disease, angina functional class and the development of coronary events. At sick IBS the changes of mainly congenital immunity which are showing in activation of NK lymphocytes (by CD16, CD 56), CD 4+CD25 +, with regulatory activity concerning synthesis are noted about - and anti-inflammatory cytokines, extent of change of the specified links of immunity reflects weight of a current of IBS. CRB is one of the most important prognostic markers of character of a current of IBS, development of complications. The thickness of a complex of intima-media of carotids arteries expressiveness of atherosclerotic defeat of an arterial wall and has prognostic value in character of a current of IBS.

 

1. Aronov D.M. Lechenie i profilaktika ateroskleroza. M.: Triada KH. 2000. 412 s.
2. Belova L.A. Biokhimija processov vospalenija i porazhenija sosudov. Rol nejjtrofilov // Biokhimija. 1997. T. 62. Vyp. 6. S. 659-668.
3. Klimov A.N. Autoimmunnaja teorija patogeneza i koncepcija modificirovannykh lipoproteidov // Vestnik AMN SSSR. 1990. № 11. S. 30-36.
4. Klimov A.N., Nagornev V.A. Metodicheskie aspekty ehtiologii i patogeneza ateroskleroza // Kardiologija. 1993. Vyp. 3. S. 5-10.
5. Klimov A.N., Nagornev V.A., Denisenko A.D.Izuchenie immunologicheskikh mekhanizmov razvitija ateroskleroza i novye metody ego diagnostiki i lechenija // Medicinskijj akademicheskijj zhurnal. 2005. T. 5. Vyp. 2. S. 18-32.
6. Klimov A.N., Nagornev V.A., Denisenko A.D., Konstantinov V.O. Autoimmunnaja teorija patogeneza ateroskleroza i novye puti ego lechenija // Vestnik RAMN. 2003. Vyp. 12. S. 29-34.
7. Nagornev V.A., Voskanjani A.N.Aterogenez kak immunovospalitelnyjj process // Vestnik RAMN. 2004. Vyp. 7. S. 3-11. 
8. Nagornev V.A., Ketlinskijj S.A. Kletochnomolekuljarnye mekhanizmy stanovlenija i razvitija aterogeneza (SD40-SD40L-immunoregu­ljatornyjj signal) // Bjuleten ehksperimentalnojj biologii. 1999. Vyp. 10. S. 364-371.
9. Nikitina E.JU., Malceva S.V., CHurakov G.A.Vlijanie lipoproteinov nizkojj plotnosti na produkciju citokinov // Trudy vtorojj mezhdunar. nauchnojj konf. «Dni immunologii v SPb\'98». 1998. C. 39.
10. CHernijj V.I., Nesterenko A.N. Narushenija immuniteta pri kriticheskikh sostojanijakh. Osobennosti diagnostiki // ZH. «Vnutrennjaja medicina». № 3. 2007.
11. JArilin A.A. Immunologija. M.: Geotar-Media. 2010. 752 s.
12. Agrawal A., Cha_Molstad H., Samols D., Kushner I. Overexpressed nuclear factor B can participate in endogenous C_reactive protein induction, and enhances the effect of C/EBPv and signal transducer and activator of transcription_3 // Immunology. 2003. V. 108. P. 539-547.
13. Aukrust P., Otterdal K., Yndestad A., Sandberg W.J., Smith C., Ueland T., Øie E., Damås J.K., Gullestad L., Halvorsen B. The complex role of T-cell-based immunity in atherosclerosis // Curr Atheroscler Rep. 2008. V. 10. P. 236-43.
14. Biasucci L.M., Liuzzo G., Fantuzzi G. et al. Increasing levels of Interleukin-1 Ra and Interleukin-6 during the first two days of hospitalisation in unstable angina are associated with increased risk of in-hospital coronary events // Circulation. 1999. V. 99. P. 2079-2084.
15. Breier G., Risau W. The role of vascular endothelial growth factor in blood vessel formation // Trends Cell. Biol. 1996. V. 6. № 12. P. 454 - 456.
16. Buttrum S.M., Hatton R., Nash G.B. Selectin-me­diated rolling of neutrophils on immobilized platelets // Blood. 1993. V. 82. № 4. P. 1165-1174.
17. Celermajer D., Sorensen K., Gooch V. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis // Lancet. 1992. V. 340. P. 1111-1115.
18. Cheng X., Yu X., Ding Y.J., Fu Q.Q., Xie J.J., Tang T.T., et al. The Th17/Treg imbalance in patients with acute coronary syndrome // Clin. Immunol. 2008. V. 127. P. 89-97.
19. Dore M., Simon S.I., Hughes B.J., Entman M.L., Smith C.W. P-selectin and CD18-mediated recruitment of canine neutrophils under conditions of shear stress // Vet. Pathol. 1995. V. 32. № 3. P. 258-268.
20. Entman M.L., Smith W.C. Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease // Cardiovasc. Res. 1994. V. 28. P. 1301-1311.
21. Erlinger T., Platz E., Rifai N., Helzlsouer K. C_reactive protein and the risk of incident colorectal cancer // JAMA. 2004. V. 291(5).P. 585-590.
22. Feletou M., Vanhoutte P.M. Endothelium-derived hyperpolarizing factor // Clin. Exp. Pharmacol. Physiol. 1996. V. 23. № 12. P. 1082 -1090. 96. Fleming I., Bauersachs Ji., Busse R. Paracrine functions of the coronary vascular endothelium // Mol. Cell. Biochem. 1996. V. 157. № 1. P. 137-145.
23. Gotsman I., Gupta R., Lichtman A.H. The influence of the regulatory T lymphocytes on atherosclerosis // Arterioscler. Thromb. Vasc. Biol. 2007. V. 27. P. 2493-1495.
24. Hansson G.K.Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005. V.352. P. 1685-1695.
25. Hansson G.K., Holm J., Jonasson J. Detection of activated T lymphocytes in the Human Atherosclerotic Plaque // Amer. J. Pathol. 1989. V. 135. P. 169-175.
26. Hansson G.K., Libby P. The immune response in atherosclerosis: A double-edged sword // Nat. Rev. Immunol. 2006. V. 6. P. 508-519.
27. Khreiss T., Jo - zsef L., Potempa L., Filep J. Conformational Rearrangement in C_Reactive Protein Is Required for Proinflammatory Actions on Human Endothelial Cells Circulation // Nat. Rev. Immunol. 2004. V. 109. P. 2016-2022.